Orbimed Advisors - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of NEVRO CORP
ValueSharesWeighting
Q3 2018$77,388,000
-23.1%
1,357,691
+7.7%
0.93%
-22.3%
Q2 2018$100,618,000
-7.9%
1,260,0910.0%1.20%
-11.4%
Q1 2018$109,212,000
+76.2%
1,260,091
+40.4%
1.35%
+72.7%
Q4 2017$61,983,000
+37.8%
897,791
+81.4%
0.78%
+82.3%
Q3 2017$44,977,000
+14.8%
494,900
-6.0%
0.43%
+4.6%
Q2 2017$39,172,000
+437.3%
526,300
+576.5%
0.41%
+395.2%
Q1 2017$7,290,00077,8000.08%
Other shareholders
NEVRO CORP shareholders Q2 2017
NameSharesValueWeighting ↓
BRAIDWELL LP 1,192,298$47,215,0011.58%
Altium Capital Management LP 76,000$3,009,6001.53%
Rock Springs Capital Management LP 1,077,900$42,684,8401.03%
Integral Health Asset Management, LLC 109,000$4,316,4000.91%
ArrowMark Colorado Holdings LLC 1,252,218$49,587,8330.59%
FOX RUN MANAGEMENT, L.L.C. 26,963$1,067,7350.43%
PDT Partners, LLC 55,715$2,206,3140.36%
FRED ALGER MANAGEMENT, LLC 1,184,000$46,886,4000.25%
Dynamic Technology Lab Private Ltd 62,819$2,4880.25%
K2 PRINCIPAL FUND, L.P. 38,000$1,504,8000.23%
View complete list of NEVRO CORP shareholders